Highlights der Pulmonalen Hypertonie-Literatur

Literatur

• 1 Cottin V, Nunes H, Brillet P Y. et al . Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity.  Eur Respir J. 2005;  26 (4) 586-593
• 2 Leuchte H H, Baumgartner R A, Nounou M E. et al . Brain natriuretic peptide is a prognostic parameter in chronic lung disease.  Am J Respir Crit Care Med. 2006;  173 (7) 744-750
• 3 Leuchte H H, El Nounou M, Tuerpe J C. et al . N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension.  Chest. 2007;  131 (2) 402-409
• 4 Barst R J, Langleben D, Badesch D. et al . Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.  J Am Coll Cardiol. 2006;  47 (10) 2049-2056
• 5 McLaughlin V V, Oudiz R J, Frost A. et al . Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension.  Am J Respir Crit Care Med. 2006;  174 (11) 1257-1263
• 6 Hoeper M M, Markevych I, Spiekerkoetter E. et al . Goal-oriented treatment and combination therapy for pulmonary arterial hypertension.  European Respiratory Journal. 2005;  26 (5) 858-863